Profile of ciclesonide for the maintenance treatment of asthma

Abstract

Ciclesonide is a nonhalogenated synthetic inhaled corticosteroid (ICS) that has been approved by the US Food and Drug Administration for the treatment of all severities of persistent asthma. It is available as a hydrofluroalkane pressurized metered-dose inhaler in two strengths, 80 mcg/activation and 160 mcg/activation, with the recommenced dosage being two… (More)
DOI: 10.2147/TCRM.S5433

2 Figures and Tables

Topics

  • Presentations referencing similar topics